Download PDF
Am J Perinatol
DOI: 10.1055/s-0043-1761298
Original Article

Gastroschisis Outcomes: Presence of Histologic Chorioamnionitis and the Impact on Time to Full Enteral Feeds and Length of Hospital Stay

Chukwudi O. Ejiofor
1   Department of Pediatrics (Neonatal-Perinatal Medicine), Franciscan Missionaries of Our Lady Health System, Lafayette, Louisiana
,
Steven Ford
2   Division of Neonatology, Department of Pediatrics, University of South Florida College of Medicine, Tampa, Florida
,
Jose R. Duncan
3   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa, Florida
,
Drew Rideout
4   Division of Pediatric Surgery, Department of Surgery, Johns Hopkins All Children's Hospital, St Petersburg, Florida
,
Ambuj Kumar
5   Department of Internal Medicine, University of South Florida College of Medicine, Tampa, Florida
,
Keyur Donda
6   Division of Neonatology, Department of Pediatrics, University of South Florida College of Medicine, Tampa, Florida
,
Jaime Flores-Torres
6   Division of Neonatology, Department of Pediatrics, University of South Florida College of Medicine, Tampa, Florida
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objective Despite improvements in our ability for early diagnosis and providing supportive care for infants with gastroschisis, it continues to be associated with long length of stay and morbidity. Intestinal dysfunction secondary to chronic inflammatory insult to exposed bowel is well known; however, little research has been done on the impact of acute inflammation in the perinatal period on intestinal function. This study's aim was to investigate the impact of acute chorioamnionitis on the time to achieve full enteral feeds and length of hospital stay.

Study Design Retrospective chart review of 60 mothers and their infants born with gastroschisis at a Level IV NICU from November 2011 to June 2020 was performed. Infants were divided into two groups based on the presence of histologic chorioamnionitis, and outcomes were compared. The primary outcome was delayed full enteral feeds (full enteral feeds after 28 days of life). The secondary outcomes were differences in their time to achieve full enteral feeds and time to hospital discharge, and prolonged length of hospital stay (discharge after 30 days of life). Univariate and multivariate logistic regression analyses were performed to assess the association between the dependent and the predictor variables.

Result Of the 60 infants enrolled, 23 (38%) had evidence of histologic chorioamnionitis. The median gestational age was 37 weeks. Fifty-four (90%) infants achieved full enteral feeds, with a median time of 24 days. Median length of hospital stay was 31 days. The presence of histologic chorioamnionitis was not associated with delayed full enteral feeds (odds ratio [OR] = 0.79; 95% confidence interval [CI] = 0.14–4.23; p = 0.80) or prolonged length of hospital stay (OR = 0.45; 95% CI = 0.1–0.23; p = 0.32) in the adjusted analysis.

Conclusion Acute placental inflammation during the perinatal period does not impact the infant's time to achieve full feeds or prolong their hospital stay. Larger studies are needed to confirm these findings.

Key Points

  • Chronic inflammatory injury to exposed bowel in utero is well known in fetuses with gastroschisis.

  • Acute inflammatory injury during perinatal period may impact enteral feeding outcomes.

  • No impact of acute placental inflammation on time to full enteral feeds.

Keywords

gastroschisis - histologic chorioamnionitis - intestinal dysfunction - enteral feeding


Publication History

Received: 02 August 2022

Accepted: 15 December 2022

Article published online:
29 January 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 O'Connell RV, Dotters-Katz SK, Kuller JA, Strauss RA. Gastroschisis: a review of management and outcomes. Obstetrical Gynecol Surg 2016; 71 (09) 537-544
    CrossrefPubMedGoogle Scholar
  • 2 Skarsgard ED. Management of gastroschisis. Curr Opin Pediatr 2016; 28 (03) 363-369
    CrossrefPubMedGoogle Scholar
  • 3 Jones AM, Isenburg J, Salemi JL. et al. Increasing prevalence of gastroschisis—14 states, 1995–2012. MMWR Morb Mortal Wkly Rep 2016; 65 (02) 23-26
    CrossrefPubMedGoogle Scholar
  • 4 Kirby RS, Marshall J, Tanner JP. et al; National Birth Defects Prevention Network. Prevalence and correlates of gastroschisis in 15 states, 1995 to 2005. Obstet Gynecol 2013; 122 (2 Pt 1): 275-281
    CrossrefPubMedGoogle Scholar
  • 5 Overcash RT, DeUgarte DA, Stephenson ML. et al; University of California Fetal Consortium*. Factors associated with gastroschisis outcomes. Obstet Gynecol 2014; 124 (03) 551-557
    CrossrefPubMedGoogle Scholar
  • 6 Wada M, Kato T, Hayashi Y. et al. Intestinal transplantation for short bowel syndrome secondary to gastroschisis. J Pediatr Surg 2006; 41 (11) 1841-1845
    CrossrefPubMedGoogle Scholar
  • 7 Torres C, Badalyan V, Mohan P. Twelve-year outcomes of intestinal failure-associated liver disease in children with short-bowel syndrome: 97% transplant-free survival and 81% enteral autonomy. JPEN J Parenter Enteral Nutr 2022; 46 (01) 197-206
    CrossrefPubMedGoogle Scholar
  • 8 Fatemizadeh R, Gollins L, Hagan J. et al. In neonatal-onset surgical short bowel syndrome survival is high, and enteral autonomy is related to residual bowel length. JPEN J Parenter Enteral Nutr 2022; 46 (02) 339-347
    CrossrefPubMedGoogle Scholar
  • 9 Guibourdenche J, Berrebi D, Vuillard E. et al. Biochemical investigations of bowel inflammation in gastroschisis. Pediatr Res 2006; 60 (05) 565-568
    CrossrefPubMedGoogle Scholar
  • 10 Morrison JJ, Klein N, Chitty LS. et al. Intra-amniotic inflammation in human gastroschisis: possible aetiology of postnatal bowel dysfunction. Br J Obstet Gynaecol 1998; 105 (11) 1200-1204
    CrossrefPubMedGoogle Scholar
  • 11 Frascoli M, Jeanty C, Fleck S. et al. Heightened immune activation in fetuses with gastroschisis may be blocked by targeting IL-5. J Immunol 2016; 196 (12) 4957-4966
    CrossrefPubMedGoogle Scholar
  • 12 Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015; 213 (4, suppl): S29-S52
    CrossrefPubMedGoogle Scholar
  • 13 Goldstein JA, Gallagher K, Beck C, Kumar R, Gernand AD. Maternal-fetal inflammation in the placenta and the developmental origins of health and disease. Front Immunol 2020; 11: 531543 DOI: 10.3389/fimmu.2020.531543.
    CrossrefPubMedGoogle Scholar
  • 14 Liu Z, Tang Z, Li J, Yang Y. Effects of placental inflammation on neonatal outcome in preterm infants. Pediatr Neonatol 2014; 55 (01) 35-40
    CrossrefPubMedGoogle Scholar
  • 15 Bersani I, Thomas W, Speer CP. Chorioamnionitis–the good or the evil for neonatal outcome?. J Matern Fetal Neonatal Med 2012; 25 (1, suppl 1): 12-16
    CrossrefPubMedGoogle Scholar
  • 16 Mestan K, Yu Y, Matoba N. et al. Placental inflammatory response is associated with poor neonatal growth: preterm birth cohort study. Pediatrics 2010; 125 (04) e891-e898
    CrossrefPubMedGoogle Scholar
  • 17 Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Society for Pediatric Pathology, Perinatal Section, Amniotic Fluid Infection Nosology Committee. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003; 6 (05) 435-448
    CrossrefPubMedGoogle Scholar
  • 18 Zani-Ruttenstock E, Zani A, Paul A, Diaz-Cano S, Ade-Ajayi N. Interstitial cells of Cajal are decreased in patients with gastroschisis associated intestinal dysmotility. J Pediatr Surg 2015; 50 (05) 750-754
    CrossrefPubMedGoogle Scholar
  • 19 Langer JC, Longaker MT, Crombleholme TM. et al. Etiology of intestinal damage in gastroschisis. I: effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg 1989; 24 (10) 992-997
    CrossrefPubMedGoogle Scholar
  • 20 Srinathan SK, Langer JC, Blennerhassett MG, Harrison MR, Pelletier GJ, Lagunoff D. Etiology of intestinal damage in gastroschisis. III: morphometric analysis of the smooth muscle and submucosa. J Pediatr Surg 1995; 30 (03) 379-383
    CrossrefPubMedGoogle Scholar
  • 21 Phillips JD, Kelly Jr RE, Fonkalsrud EW, Mirzayan A, Kim CS. An improved model of experimental gastroschisis in fetal rabbits. J Pediatr Surg 1991; 26 (07) 784-787
    CrossrefPubMedGoogle Scholar
  • 22 Owaki T, Imai K, Miki R. et al. Multiple cytokine analysis in gastroschisis: association with adverse outcomes including fetal brain damage. Cytokine 2021; 138: 155406
    CrossrefPubMedGoogle Scholar
  • 23 Fasching G, Haeusler M, Mayr J, Schimpl G, Haas J, Puerstner P. Can levels of interleukins and matrix metalloproteinases in the amniotic fluid predict postnatal bowel function in fetuses with gastroschisis?. J Pediatr Surg 2005; 40 (12) 1887-1891
    CrossrefPubMedGoogle Scholar
  • 24 Abdel-Latif ME, Bolisetty S, Abeywardana S, Lui K. Australian and New Zealand Neonatal Network. Mode of delivery and neonatal survival of infants with gastroschisis in Australia and New Zealand. J Pediatr Surg 2008; 43 (09) 1685-1690
    CrossrefPubMedGoogle Scholar
  • 25 Kirollos DW, Abdel-Latif ME. Mode of delivery and outcomes of infants with gastroschisis: a meta-analysis of observational studies. Arch Dis Child Fetal Neonatal Ed 2018; 103 (04) F355-F363
    CrossrefPubMedGoogle Scholar
  • 26 Lopez A, Benjamin RH, Raut JR. et al. Mode of delivery and mortality among neonates with gastroschisis: a population-based cohort in Texas. Paediatr Perinat Epidemiol 2019; 33 (03) 204-212
    CrossrefPubMedGoogle Scholar